The Effect of Sodium-Glucose Co-Transporter 2 Inhibitors on Stroke and Atrial Fibrillation: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

The Effect of Sodium-Glucose Co-Transporter 2 Inhibitors on Stroke and Atrial Fibrillation: A Systematic Review and Meta-Analysis

Published:2023-04 Issue:4 Volume:48 Page:101582
ISSN:0146-2806
Container-title:Current Problems in Cardiology
language:en
Short-container-title:Current Problems in Cardiology

Author:

Fatima Kaneez,Suri Azeema,Rija Aiman^ORCID,Kalim Sara,Javaid Sarmad,Arif Zainab,Abedin Mariam Farhan Essa,Raza Yusra,Kalim Nimra,Azam Fatima,Musani Sarah

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference21 articles.

1. Sotagliflozin in patients with diabetes and chronic kidney disease;Bhatt;New Eng J Med,2020

2. Cardiovascular outcomes with Ertugliflozin in Type 2 diabetes;Cannon;New Engl J Med,2020

3. Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;New Eng J Med,2017

4. Dapagliflozin and cardiovascular outcomes in type 2 diabetes;Wiviott;New Eng J Med,2018

5. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes;Zinman;New Eng J Med,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of sodium-glucose transporter 2 inhibitors on stroke in patients with type 2 diabetes: A meta-analysis;Journal of Stroke and Cerebrovascular Diseases;2024-08

2. Diabetes and Stroke: Impact of Novel Therapies for the Treatment of Type 2 Diabetes Mellitus;Biomedicines;2024-05-16

3. Efficacy of dapagliflozin in improving arrhythmia-related outcomes after ablation for atrial fibrillation: a retrospective single-center study;Clinical Research in Cardiology;2024-02-15

4. Optimal Timing for Atrial Fibrillation Patients to Undergo Catheter Ablation: Insights from Long-Term Outcome Studies;2024-02-06

5. Atrial fibrillation: comorbidities, lifestyle, and patient factors;The Lancet Regional Health - Europe;2024-02